Suppr超能文献

[中成药二次开发的策略与核心技术]

[Strategy and core technologies for the secondary development of Chinese patent medicine].

作者信息

Zhagn Bo-Li, Fan Xiao-Hui, Liu Yang, Qu Hai-Bin, Zhang Jun-Hua, Chegn Yi-Yu

机构信息

Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.

Department of Chinese Medicine Science and Engineering, Zhejiang University, Hangzhou 310058, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2013 Nov;38(22):3797-800.

Abstract

Secondary development of Chinese Patent Medicine (CPM) is an effective and innovation-driven way for the leaping development of Chinese medicine industry with less investment and faster return. Aim to improving the efficacy, safety and batch-to-batch consistency of CPMs, the theory and methodology for the secondary development of CPMs, mode for cultivating superior CPM, approaches to reforming the pharmaceutical technology and the corresponding core technologies were proposed in this paper, which is summarized as 'One objective, Three analyses, Five definitudes and Seven improvements'.

摘要

中成药二次开发是中药产业实现跨越式发展的一条有效且创新驱动的途径,具有投资少、回报快的特点。本文旨在提高中成药的疗效、安全性和批间一致性,提出了中成药二次开发的理论与方法、培育优质中成药的模式、改革制药工艺的途径及相应的核心技术,概括为“一个目标、三个分析、五个明确、七个改进”。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验